Oxcarbazepine in the treatment of painful diabetic neuropathy: A randomized, placebo-controlled study

被引：0
|
作者：
Riviere, M. -E.
Wan, Y.
Hopwood, M.
Liebel, J.
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Nova Pharmaceut Corp, E Hanover, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [31] Effectiveness of oxcarbazepine in symptomatic treatment of painful diabetic neuropathy - Comment
    Arkkila, Perttu
    NEUROLOGY INDIA, 2006, 54 (02) : 177 - 177
  • [32] Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial
    Mu, Yiming
    Liu, Xiaomin
    Li, Quanmin
    Chen, Kangning
    Liu, Yu
    Lv, Xiaofeng
    Xu, Xiangjin
    Fan, Dongsheng
    Shang, Ningxiu
    Yang, Ruoyong
    Pauer, Lynne
    Pan, Changyu
    JOURNAL OF DIABETES, 2018, 10 (03) : 256 - 265
  • [33] Lamotrigine reduces painful diabetic neuropathy - A randomized, controlled study
    Eisenberg, E
    Lurie, Y
    Braker, C
    Daoud, D
    Ishay, A
    NEUROLOGY, 2001, 57 (03) : 505 - 509
  • [34] Lacosamide in painful diabetic peripheral neuropathy - A phase 2 double-blind placebo-controlled study
    Rauck, Richard L.
    Shaibani, Aziz
    Biton, Victor
    Simpson, Jqff
    Koch, Brigitte
    CLINICAL JOURNAL OF PAIN, 2007, 23 (02): : 150 - 158
  • [35] GANGLIOSIDES IN THE TREATMENT OF DIABETIC NEUROPATHY - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING STUDY
    LINGETTI, M
    COTO, V
    RENGO, F
    SGAMBATO, S
    INNOCENTI, A
    FIORI, MG
    DIABETES NUTRITION & METABOLISM, 1992, 5 (04) : 275 - 282
  • [36] Placebo-controlled trial assessing the efficacy and safety of lacosamide in painful distal diabetic neuropathy
    Wymer, James M.
    Garrison, C.
    Simpson, J.
    Koch, B.
    ANNALS OF NEUROLOGY, 2006, 60 : S68 - S68
  • [37] A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy
    Vinik, Aaron I.
    Shapiro, Douglas Y.
    Rauschkolb, Christine
    Lange, Bernd
    Karcher, Keith
    Pennett, Deborah
    Etropolski, Mila S.
    DIABETES CARE, 2014, 37 (08) : 2302 - 2309
  • [38] Neuromodulation for Treatment of Painful Diabetic Neuropathy: A Multicenter Randomized Controlled Trial
    Petersen, Erika
    Stauss, Thomas
    White, Judith L.
    Sills, Shawn M.
    Amirdelfan, Kasra
    Guirguis, Maged
    Xu, Jijun
    Yu, Cong
    Nairizi, Ali
    Patterson, Denis G.
    Galan, Vincent
    Mehta, Neel
    Lad, Shivanand P.
    Dibenedetto, David
    Wu, Paul W.
    Nasr, Christian E.
    Taylor, Rod
    Brooks, Elizabeth S.
    Subbaroyan, Jeyakumar
    Gliner, Bradford
    Caraway, David L.
    Mekhail, Nagy
    DIABETES, 2020, 69
  • [39] A randomized, double-blind, placebo-controlled trial to investigate safety and efficacy of SPM 927 in painful diabetic neuropathy
    Rauck, R
    Shaibani, A
    Biton, V
    Simpson, J
    Koch, B
    Rauschkolb, C
    NEUROLOGY, 2004, 62 (07) : A441 - A441
  • [40] Prediction of Individual Analgesic Response to Intravenous Lidocaine in Painful Diabetic Peripheral Neuropathy A Randomized, Placebo-controlled, Crossover Trial
    Todorovic, Marko S.
    Frey, Karen
    Swarm, Robert A.
    Bottros, Michael
    Rao, Lesley
    Tallchief, Danielle
    Kraus, Kristin
    Meacham, Kathleen
    Bakos, Kristopher
    Zang, Xiaowei
    Lee, Jong Bong
    Kagan, Leonid
    Haroutounian, Simon
    CLINICAL JOURNAL OF PAIN, 2022, 38 (02): : 65 - 76
12345